Summary:
This clinical study evaluates the safety, efficacy and tolerability of an investigational medicine for patients with Schizophrenia.
Qualified Participants Must:
• Be 18 years old or older
•
Have a diagnosis of Schizophrenia
•
Be generally healthy
Qualified Participants May Receive:
Eligible participants will receive study medication or placebo, study-related care, and diagnostic exams at no cost.